Canlyniadau Chwilio - Kwok, Kenneth

A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus gan Dombi, Theresa, Kwok, Kenneth K, Sultan, Marla B

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis gan Fleischmann, Roy, Strand, Vibeke, Wilkinson, Bethanie, Kwok, Kenneth, Bananis, Eustratios

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program gan Mariette, Xavier, Chen, Connie, Biswas, Pinaki, Kwok, Kenneth, Boy, Mary G.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Moral judgment modulation by disgust is bi-directionally moderated by individual sensitivity gan Ong, How Hwee, Mullette-Gillman, O’Dhaniel A., Kwok, Kenneth, Lim, Julian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib gan Bird, Paul, Hall, Stephen, Nash, Peter, Connell, Carol A, Kwok, Kenneth, Witcombe, David, Thirunavukkarasu, Krishan

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studi... gan Fleischmann, Roy, Wollenhaupt, Jürgen, Takiya, Liza, Maniccia, Anna, Kwok, Kenneth, Wang, Lisy, van Vollenhoven, Ronald F

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Dopaminergic Polymorphisms Associated with Time-on-Task Declines and Fatigue in the Psychomotor Vigilance Test gan Lim, Julian, Ebstein, Richard, Tse, Chun-Yu, Monakhov, Mikhail, Lai, Poh San, Dinges, David F., Kwok, Kenneth

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Tofacitinib with conventional synthetic disease‐modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient‐reported outcomes from a Phase 3 randomized con... gan Li, Zhanguo, An, Yuan, Su, Houheng, Li, Xiangpei, Xu, Jianhua, Zheng, Yi, Li, Guiye, Kwok, Kenneth, Wang, Lisy, Wu, Qizhe

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis gan Rubin, David T., Modesto, Irene, Vermeire, Séverine, Danese, Silvio, Ng, Siew C., Kwok, Kenneth K., Koram, Nana, Jones, Thomas V.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population gan Hall, Stephen, Nash, Peter, Rischmueller, Maureen, Bossingham, David, Bird, Paul, Cook, Nicola, Witcombe, David, Soma, Koshika, Kwok, Kenneth, Thirunavukkarasu, Krishan

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies gan van der Heijde, Désirée, Landewé, Robert B M, Wollenhaupt, Jürgen, Strengholt, Sander, Terry, Ketti, Kwok, Kenneth, Wang, Lisy, Cohen, Stanley

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials gan Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials gan Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme gan Curtis, Jeffrey R, Lee, Eun Bong, Kaplan, Irina V, Kwok, Kenneth, Geier, Jamie, Benda, Birgitta, Soma, Koshika, Wang, Lisy, Riese, Richard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs gan Charles-Schoeman, Christina, Burmester, Gerd, Nash, Peter, Zerbini, Cristiano A F, Soma, Koshika, Kwok, Kenneth, Hendrikx, Thijs, Bananis, Eustratios, Fleischmann, Roy

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis gan Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment gan Winthrop, Kevin L., Curtis, Jeffrey R., Yamaoka, Kunihiro, Lee, Eun Bong, Hirose, Tomohiro, Rivas, Jose L., Kwok, Kenneth, Burmester, Gerd R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Se... gan Mueller, Ruediger B., Schulze-Koops, Hendrik, Furst, Daniel E., Cohen, Stanley B. , Kwok, Kenneth, Wang, Lisy, Killeen, Tim, von Kempis, Johannes

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses gan Strand, Vibeke, Kavanaugh, Arthur, Kivitz, Alan J., van der Heijde, Désirée, Kwok, Kenneth, Akylbekova, Ermeg, Soonasra, Arif, Snyder, Mark, Connell, Carol, Bananis, Eustratios, Smolen, Josef S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management gan Sands, Bruce E, Colombel, Jean-Frédéric, Ha, Christina, Farnier, Michel, Armuzzi, Alessandro, Quirk, Daniel, Friedman, Gary S, Kwok, Kenneth, Salese, Leonardo, Su, Chinyu, Taub, Pam R

Cael y testun llawn Cael y testun llawn Cael y testun llawn